Literature DB >> 22346784

Th17 responses are not induced in dextran sodium sulfate model of acute colitis.

Yoon Suk Kim1, Min Ho Lee, Ahn Seung Ju, Ki-Jong Rhee.   

Abstract

Dextran sodium sulfate (DSS) is a widely used chemical model for inflammatory bowel disease (IBD). It is thought that imbalances in the T helper (Th) cell subsets contribute to IBD. Recent studies suggest that the acute DSS-colitis model is polarized toward a Th1/Th17 profile based on RT-PCR analysis of colonic tissues. In the current study we determined whether colonic Th cells from DSS-colitis mice were skewed toward the Th17 profile. Mice were treated with 5% DSS for 7 days and colonic T cells isolated and examined for production of IFN-γ (Th1 cell), IL-4 (Th2 cell) and IL-17 (Th17 cell) by intracellular flow cytometry. We found that the percentage of colonic Th17 cells were similar to non-treated controls but the percentage of Th1 cells were elevated in DSS-colitis mice. These results suggest that in the acute DSS-colitis model the colonic Th cells exhibit a Th1 profile and not a Th17 profile.

Entities:  

Keywords:  Colitis; Dextran sodium sulfate; Inflammatory bowel disease; Th17 cell

Year:  2011        PMID: 22346784      PMCID: PMC3275713          DOI: 10.4110/in.2011.11.6.416

Source DB:  PubMed          Journal:  Immune Netw        ISSN: 1598-2629            Impact factor:   6.303


Inflammatory bowel disease (IBD) is defined as a chronic inflammatory disorder of the gastrointestinal tract and is classified as Crohn's disease or ulcerative colitis based on distinct clinical, endoscopic and histopathological features. Multiple studies suggest that microbial, environmental and genetic factors contribute to the pathogenesis of this disorder [reviewed in (1,2)]. These factors ultimately culminate in an inappropriate adaptive immune response which perpetuates the chronic intestinal inflammation. Much of our mechanistic understanding of IBD pathogenesis has been extrapolated from studies of animal models (3). Among these animal model systems, the oral uptake of dextran sodium sulfate (DSS) by mice induces a phenotype similar to ulcerative colitis and is widely used by researchers to study IBD (4). DSS damages the colonic epithelial barrier which then exposures the underlying tissues to bacterial flora and results in subsequent inflammation and induction of Th cell responses. The murine DSS-induced colitis model recapitulates many aspects of human IBD such as cytokine dysregulation which is a key feature of IBD pathogenesis (5). This dysregulation is thought to be due to the imbalance of T helper (Th) cell subsets such as T helper 1 (Th1) and T helper 2 (Th2) cells. Crohn's disease is characterized by a Th1 cytokine profile mediated by the cytokines IFN-γ, IL-12 and TNF-α. In contrast, ulcerative colitis is characterized by a Th2 cytokine profile mediated by the cytokines IL-4 and IL-5. However, this simplified classification has been challenged by studies suggesting that Crohn's disease is characterized by the production of IL-17 (6,7). In an acute model of DSS-colitis, Alex et al. showed that mice give DSS for 7 days exhibited an increase in IL-12 and IL-17 suggesting an induction of a Th1/Th17 profile (7). However, in this study protein and mRNA samples from whole colonic tissues and serum were analyzed and not Th cells. Therefore, it is unclear if indeed the Th cells were also polarized toward the Th1/Th17 subset. In this current report, we examined the percentages of Th1/Th2/Th17 cells in the colonic tissues of DSS-treated mice to determine whether the Th cells were polarized to the Th1 and/or Th17 subset. Six-week-old female C57Bl/6 mice (ORIENT BIO, Korea) powere given 5% (w/v) DSS (MW 30,000~45,000, MP Bioche-pulation. micals, Solon, OH, USA) in the drinking water and fed ad libitum for 7 days. Control mice received water without DSS. This study was approved by the Institutional Review Board of Yonsei University at Wonju, South Korea. We isolated the colonic lymphocytes and conducted intracellular staining by flow cytometry as previously described (8). In brief, pooled large intestines (3 mice per group) were minced and enzymatically digested with Liberase™ (Roche, USA) and DNase I (Roche). The lymphocytes were isolated by using a Percoll gradient. Cells were stimulated for 4 hr in vitro in the presence of PMA (30 nM) (Promega, USA), ionomycin (1µM) (Sigma, USA) and GolgiPlug™ (BD Biosciences, USA). Then the cells were washed, fixed and stained for cell surface markers and intracellular cytokines. Cells were analyzed using FACSCalibur (BD Biosciences). Mice administered DSS developed fulminant colitis as determined by hematoxylin and eosin (H&E) staining of the colon (Fig. 1). In addition, the DSS-treated mice exhibited rectal bleeding, decrease in body weight and shortening of the colon length which are all characteristic features of DSS-colitis (data not shown) (4). We analyzed the Th cell population (i.e., CD3+4+ T cells) for production of the intracellular cytokines IFN-γ, IL-4 and IL-17 and found that compared to the control mice Th cells from the DSS-treated mice did not show an increase in IL-17 producing CD3+4+ T cells (DSS 6.8% versus control 8.3%) (Fig. 2). Similarly, the percentages of IL-4 producing CD3+4+ T cells were comparable in both groups of mice (DSS 2.2% versus control 2.6%). In contrast, the percentages of IFN-γ producing CD3+4+ T cells were increased two-fold in the DSS-treated group compared to the control group (DSS 12.1% versus control 5.6%). These results indicate that in the acute DSS-colitis model the Th cells exhibit a predominantly Th1 profile.
Figure 1

H&E staining of colons from control mice and DSS-treated mice. Mice were administered 5% DSS in the drinking water for 7 days.

Figure 2

Intracellular cytokine flow cytometric analysis of colonic CD3+4+T cells from the large intestines of DSS-treated mice and control mice. After one week of DSS treatment, isolated lymphocytes were treated with PMA, ionomycin, GolgiPlug™ for 4 hours and stained with antibodies against cell surface markers and cytokines. Dot plots were derived from cells gated on the CD3+4+ T cell population. Data are representative of three independent experiments. The numbers inside each quadrant indicate the percentage of the cell population.

Ostensibly these results appear in conflict with several recent studies that were published during the preparation of this manuscript (9-12). The results from these studies suggest that the DSS colitis model is Th1/Th17 polarizing. The aforementioned studies differ from our study in that the mouse strains used, DSS dose and DSS administration times are different. Studies have demonstrated that the DSS dose affects the extent of colonic inflammation which may also lead to different Th differentiation programs (13). The results from this current study indicate that in the acute DSS-colitis model the Th cell cytokine profile is strictly Th1 polarizing. Therefore, we suggest that the IL-17 production in the DSS model is due to other cell types. Several studies have indicated IL-17 can be produced by CD8+ T cells (14), NKT cells (15,16), neutrophils (17) and paneth cells (18). Recent studies have shown that the colonic lamina propria γ/δ T cells can also be a source of IL-17 producing cells (8,19). We did not find an increase in CD3+4- IL-17 producing cells in the DSS treated mice suggesting that γ/δ T cells are not a major contributor of IL-17 in this model (data not shown). In Crohn's disease, the cytokine makeup is considered to be skewed toward the Th1/Th17 profile whereas in ulcerative colitis Th2 profile dominates. Therefore, our data suggests that although the murine DSS model histopathologically mimics ulcerative colitis the Th response is not Th2. Additionally, the Th1/Th17 response observed in human Crohn's disease was also not mirrored in the murine DSS-colitis model. The results from this current study raise a cautionary note when extrapolating results from murine DSS studies to human IBD. Our flow cytometric results suggest that the Th response is skewed toward the Th1 profile in our DSS model. However, supplemental experiments examining mRNA levels of the cytokine genes IFN-γ, IL-4 and IL-17 by real-time PCR would provide a further validation for our conclusion. Similarly, examining expression levels of the Th cell promoting transcription factors T-bet (Th1), GATA-3 (Th2) and ROR-γ (Th17) from lamina propria CD3+CD4+ sorted cells should provide a more comprehensive and definitive answer. In conclusion, we provide evidence suggesting that in the murine model of acute DSS-colitis the colonic T cells are polarized to a Th1 profile and not a Th17 profile.
  19 in total

1.  P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis.

Authors:  Jeffrey B Brown; Paul Cheresh; Zheng Zhang; Hyunji Ryu; Elizabeth Managlia; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2012-02       Impact factor: 5.325

Review 2.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

Review 3.  Why study animal models of IBD?

Authors:  Warren Strober
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

Review 4.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger.

Authors:  Stephane Ferretti; Olivier Bonneau; Gerald R Dubois; Carol E Jones; Alexandre Trifilieff
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

6.  Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.

Authors:  Reiko Ito; Masakazu Kita; Masaharu Shin-Ya; Tsunao Kishida; Atsuyo Urano; Ryusuke Takada; Junichi Sakagami; Jiro Imanishi; Yoichiro Iwakura; Takeshi Okanoue; Toshikazu Yoshikawa; Keisho Kataoka; Osam Mazda
Journal:  Biochem Biophys Res Commun       Date:  2008-09-15       Impact factor: 3.575

7.  Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

Authors:  Jeong-Seok Nam; Masaki Terabe; Mi-Jin Kang; Helen Chae; Nga Voong; Yu-An Yang; Arian Laurence; Aleksandra Michalowska; Mizuko Mamura; Scott Lonning; Jay A Berzofsky; Lalage M Wakefield
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

8.  Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.

Authors:  Philip Alex; Nicholas C Zachos; Thuan Nguyen; Liberty Gonzales; Tian-E Chen; Laurie S Conklin; Michael Centola; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

9.  Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.

Authors:  Yasuaki Sanada; Tsunekazu Mizushima; Yasuyuki Kai; Junichi Nishimura; Hiroshi Hagiya; Haruto Kurata; Hirotaka Mizuno; Etsuko Uejima; Toshinori Ito
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  IL-17 produced by Paneth cells drives TNF-induced shock.

Authors:  Nozomi Takahashi; Ineke Vanlaere; Riet de Rycke; Anje Cauwels; Leo A B Joosten; Erik Lubberts; Wim B van den Berg; Claude Libert
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

View more
  8 in total

1.  Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Authors:  Fabiany da Costa Gonçalves; Natália Schneider; Fernanda Otesbelgue Pinto; Fabíola Schons Meyer; Fernanda Visioli; Bianca Pfaffenseller; Patrícia Luciana da Costa Lopez; Eduardo Pandolfi Passos; Elizabeth Obino Cirne-Lima; Luíse Meurer; Ana Helena Paz
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Oral tolerance is inducible during active dextran sulfate sodium-induced colitis.

Authors:  Satoshi Ino; Chikara Kohda; Kosuke Takeshima; Hiroki Ishikawa; Tomoko Norose; Toshiko Yamochi; Masafumi Takimoto; Hiroshi Takahashi; Kazuo Tanaka
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  Ginseng Berry Extract Attenuates Dextran Sodium Sulfate-Induced Acute and Chronic Colitis.

Authors:  Wei Zhang; Li Xu; Si-Young Cho; Kyung-Jin Min; Tatsuya Oda; LiJun Zhang; Qing Yu; Jun-O Jin
Journal:  Nutrients       Date:  2016-04-05       Impact factor: 5.717

Review 4.  Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease.

Authors:  Brunette Katsandegwaza; William Horsnell; Katherine Smith
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

5.  Protective effect of Laminaria japonica with probiotics on murine colitis.

Authors:  Seok-Jae Ko; Youngmin Bu; Jinhyun Bae; Yu-mi Bang; Jinsung Kim; Hyejung Lee; Lee Beom-Joon; Yoo Hye Hyun; Jae-Woo Park
Journal:  Mediators Inflamm       Date:  2014-05-18       Impact factor: 4.711

6.  Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis.

Authors:  Zhiqi Chen; Kai Yu; Fang Zhu; Reginald Gorczynski
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

7.  Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.

Authors:  Suman Acharya; Maheshwor Timilshina; Liyuan Jiang; Sabita Neupane; Dong-Young Choi; Sang Won Park; Sang Yeul Lee; Byeong-Seon Jeong; Jung-Ae Kim; Tae-Gyu Nam; Jae-Hoon Chang
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

Review 8.  Intestinal resident macrophages: Multitaskers of the gut.

Authors:  Maria Francesca Viola; Guy Boeckxstaens
Journal:  Neurogastroenterol Motil       Date:  2020-03-28       Impact factor: 3.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.